Tower Research Capital »

Lyra Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.5k 534 6.53
2025-06-30 $13k 1.5k 8.96

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Lyra Therapeutics

Perceptive Advisors
Sabby Management
Vanguard Group
Ikarian Capital
Citadel Advisors
Geode Capital Management
UBS Group
Morgan Stanley
BlackRock
Royal Bank of Canada
Tower Research Capital
FMR
Signature Resources Capital Management
EverSource Wealth Advisors
Jones Financial Companies, L.L

View all funds holding Lyra Therapeutics